🔎 Trials Near Me

Gara Jalqabaatti › Sukkaraa Gosa 2 › Connecticut

Qorannoo klinikaalii Sukkaraa Gosa 2 Connecticut keessatti

Qorannoo 14 Sukkaraa Gosa 2 f Connecticut keessatti hirmaatuu jiru.

Magaalota Connecticut keessatti

Takkalaa qorannoo (Ingiliffa)

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Chase Medical Research LLC, Waterbury
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
  • Cardiology Associates of Fairfield County, Stamford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07064473

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • New England Research Associates, LLC, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Yale University, New Haven
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Yale School of Medicine, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 18 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07282613

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07662044

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Yale Diabetes Research, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Yale, New Haven
Namoota walitti qabaa jira
Umuriin 14 hanga 75 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT07579702

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

  • Yale University, New Haven
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07376655

Ultrasound Effects on Glycemic Control in T2DM

  • Yale-New Haven Hospital, New Haven
Namoota walitti qabaa jira
Umuriin 21 hanga 75 · Saalaa hunda · Haaromfame 27-Ama-2026 · NCT05354947

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

  • Fair Haven Community Health Care (FHCHC), New Haven
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Mud-2025 · NCT06658067

Diabetes Learning in Virtual Environments Just in Time for Community Reentry

  • University of Connecticut, Storrs
  • University of Connecticut, Storrs Mansfield
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2025 · NCT05286892

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

  • Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 14-Ama-2025 · NCT05776563

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.